Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.550
-0.050 (-1.39%)
At close: Jul 30, 2025, 4:00 PM
3.501
-0.049 (-1.39%)
After-hours: Jul 30, 2025, 6:59 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $450.27 million as of July 30, 2025. Its market cap has decreased by -44.68% in one year.
Market Cap
450.27M
Enterprise Value
197.39M
1-Year Change
-44.68%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $450.27M, a decrease of -80.08%. That is a compound annual growth rate of -33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 455.97M | -45.46% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |